'Normal for now' or 'at future risk': A double standard for selecting young and older living kidney donors

American Journal of Transplantation

Volumn 10, Issue 4, 2010, Pages 737-741

  Steiner, R W ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Kidney transplantation; Live donor transplantation; Old young

Indexed keywords

AFRICAN AMERICAN; AGE DISTRIBUTION; CAUCASIAN; CAUSAL ATTRIBUTION; CLINICAL EVALUATION; DIABETIC NEPHROPATHY; ETHNIC DIFFERENCE; HUMAN; HYPERTENSION; KIDNEY FAILURE; LIVING DONOR; NEGRO; OBESITY; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DECISION MAKING; HUMANS; INFANT; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; MIDDLE AGED; UNITED STATES; YOUNG ADULT;

EID: 77949864833     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03023.x     Document Type: Review

References (23)

1. Reese PP, Feldman HI, McBride MA, Anderson K, Asch DA, Bloom RD. Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers. Am J Transplant 2008 8 : 2062 2070.
2. Mandelbrot DA, Pavlakis M, Danovitch GM et al. The medical evaluation of living kidney donors. A survey of US transplant centers. Am J Transplant 2007 7 : 2333 2343.
3. Reese P, Caplan A, Kesselheim A, Bloom R. Creating a medical, ethical, and legal framework for complex living kidney donors. Clin J Am Soc Nephrol 2006 1 : 628 633.
4. Remuzzi G, Schieppati A, Ruggenenti P. Nephropathy in patients with type 2 diabetes. N Engl J Med 2002 346 : 1145 1151.
5. Ibrahim HN, Hostetter TH. Diabetic nephropathy. J Am Soc Nephrol 1997 8 : 487 493.
6. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA 2003 290 : 1884 1890.
7. http://www.diabetes.niddk.nih.gov/DM/PUBS/statistics.
8. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004 351 : 1296 1305.
9. Kiberd BA, Clase CM. Cumulative risk for developing end-stage renal disease in the U.S. population. J Am Soc Nephrol 2002 13 : 1635 1644.
10. Gibney EM, King AL, Maluf DG, Garg AX, Parikh CR. Living kidney donors requiring transplantation: Focus on African Americans. Transplantation 2007 84 : 647 649.
11. Ibrahim HN, Foley R, Tan L et al. Long-term consequences of kidney donation. N Engl J Med 2009 360 : 459 469.
12. Bauer JH, Reams GP, Wu Z. The aging hypertensive kidney: Pathophysiology and therapeutic options. Am J Med 1991 90 : 21S 27S.
13. Vasan RS, Martin GL, Leip EP et al. Impact of high normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001 345 : 1291 1297.
14. Zarif L, Covic A, Iyengar S, Sehgal A, Sedor J, Schelling J. Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis. Nephrol Dial Transplant 2000 15 : 1801 1807.
15. Schlessinger SD, Tankersley MR, Curtis JJ. Clinical documentation of end-stage renal disease due to hypertension. Am J Kid Dis 1994 23 : 655 660.
16. Steiner RW, Danovitch G. The medical evaluation and risk estimation of end-stage renal disease for living kidney donors. In : Steiner RW, ed. Educating, evaluating, and selecting living kidney donors. Dordrecht, The Netherlands : Kluwer Academic Publishers, 2004 : 51 79.
17. Walker WG, Neaton JD, Cutler JA, Neuwirth R, Cohen JD, the MRFIT Research Group. Renal function change in hypertensive members of the multiple risk factor intervention trial. Racial and treatment effects JAMA 1992 268 : 3085 3091.
18. Freedman BI, Sedor JR. Hypertension-associated kidney disease: Perhaps no more. J Am Soc Nephrol 2008 19 : 2047 2051.
19. Hsu C. Does non-malignant hypertension cause renal insufficiency? Evidence-based perspective. Curr Opin Nephrol Hyperten 2002 11 : 267 272.
20. Cherikh W, Fan PY, Carroll C, Maghirang J, Randall H, Young C. Prior living kidney donors who subsequently needed chronic maintenance dialysis. Abstract 533, American Transplant Congress, June 2, 2009, Toronto, ON, Canada.
21. Steiner RW, Gert B. Ethical selection of living kidney donors. Am J Kidney Dis 2000 36 : 677 686.
22. Steiner R, Matas AJ. First things first: Laying the ethical and factual groundwork for living kidney donor selection standards. Am J Transplant 2008 8 : 930 932.
23. Gregg EW, Cheng YJ, Narayan KM, Thompson TJ, Williamson DF. The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976-2004. Prev Med 2007 45 : 348 352.